Evidence map›Paper›PMID 35806019›Full record

ArticleInternational journal of molecular sciences2022

KSK-74: Dual Histamine H

Kamil Mika, Małgorzata Szafarz, Monika Zadrożna, Barbara Nowak, Marek Bednarski, Katarzyna Szczepańska, Krzysztof Pociecha, Monika Kubacka, Noemi Nicosia, Izabela Juda and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. The Effect of KSK-94, a Dual Histamine HPharmaceuticals (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Evaluation of Some Safety Parameters of Dual Histamine HInternational journal of molecular sciences · 2023
    Article
  5. Chemical Constituents from the Leaves ofMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Kamil MikaDepartment of Pharmacological Screening, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
Małgorzata SzafarzDepartment of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
Monika ZadrożnaDepartment of Cytobiology, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
Barbara NowakDepartment of Cytobiology, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
Marek BednarskiDepartment of Pharmacological Screening, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
Katarzyna SzczepańskaTechnology and Biotechnology of Medical Remedies, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.ORCID 0000-0002-6110-9400
Krzysztof PociechaDepartment of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
Monika KubackaDepartment of Pharmacological Screening, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.ORCID 0000-0003-4878-0723
Noemi NicosiaDepartment of Pharmacological Screening, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.ORCID 0000-0002-9453-1237
Izabela JudaDepartment of Cytobiology, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
Katarzyna Kieć-KononowiczTechnology and Biotechnology of Medical Remedies, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
Magdalena KotańskaDepartment of Pharmacological Screening, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.ORCID 0000-0002-3946-1192
Jagiellonian University · PLUniversity of Messina · IT

Funding

National Science Center 2016/23/B/NZ7/01063
6 · The paper itself

Abstract

Many studies involving compounds that enhance histamine release, such as histamine H

Indexed as

Receptors, Histamine H3AnimalsHistamineHistamine AntagonistsLigandsObesityRatsReceptors, sigmaWeight GainHistamineHistamine AntagonistsLigandsReceptors, Histamine H3Receptors, sigmasigma-2 receptorexcessive eating modelhistamine H3 receptor ligandsobesitypalatable dietsigma-2 receptor ligands

Identifiers

PMID35806019
PMCPMC9266460
OpenAlexW4283513681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.